# EDGAR Filing Document

**Accession Number:** 0001596946
**File Stem:** 0000899243-23-003740
**Filing Date:** 2023-2
**Character Count:** 6770
**Document Hash:** 483326c49be49bb3c7e49bf038887946
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000899243-23-003740.hdr.sgml**: 20230202

**ACCESSION NUMBER**: 0000899243-23-003740

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230202

**DATE AS OF CHANGE**: 20230202

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bonasso Vittoria
- **CENTRAL INDEX KEY:** 0001866108

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36415
- **FILM NUMBER:** 23583376

**MAIL ADDRESS:**
- **STREET 1:** C/O QUOTIENT LIMITED, B1, BUSINESS PARK
- **STREET 2:** TERRE BONNE, ROUTE DE CRASSIER 13
- **CITY:** EYSINS
- **STATE:** V8
- **ZIP:** 1262
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Quotient Ltd
- **CENTRAL INDEX KEY:** 0001596946
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 264719797
- **STATE OF INCORPORATION:** Y9
- **FISCAL YEAR END:** 0331

**BUSINESS ADDRESS:**
- **STREET 1:** 28 ESPLANADE
- **CITY:** SAINT HELIER
- **STATE:** Y9
- **ZIP:** JE2 3QA
- **BUSINESS PHONE:** 41274832286

**MAIL ADDRESS:**
- **STREET 1:** 28 ESPLANADE
- **CITY:** SAINT HELIER
- **STATE:** Y9
- **ZIP:** JE2 3QA

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bonasso Vittoria<br><sub>(Last) (First) (Middle)</sub><br>C/O QUOTIENT LIMITED, BUSINESS PARK<br>TERRE BONNE, ROUTE DE CRASSIER 13<br><sub>(Street)</sub><br>EYSINS, V8 1262<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-31 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Quotient Ltd [ QTNT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 2023-01-31 |  | M |  | 167 | A | <sup>(1)</sup> | 390 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2023-01-31 |  | M |  |  | 167 | <sup>(2)</sup> | <sup>(2)</sup> | Ordinary Shares | 167 | $0.00 | 166 | D |  |
| Restricted Stock Units | <sup>(1)</sup> |  |  |  |  |  |  | <sup>(3)</sup> | <sup>(3)</sup> | Ordinary Shares | 57 |  | 114 | D |  |
| Ordinary Share Option(Right to Buy) | $174.80 |  |  |  |  |  |  | <sup>(4)</sup> | 2031-06-10 | Ordinary Shares | 175 |  | 175 | D |  |

---

### Footnotes:

(1) Restricted Stock Units convert into ordinary shares on a one-for-one basis.

(2) On January 31, 2021 the Reporting Person was granted 500 Restricted Stock Units, of which 334 have vested and have converted into ordinary shares. The remaining 166 Restricted Stock Units will vest on January 31, 2024.

(3) On June 10, 2021, the Reporting Person was granted 171 Restricted Stock Units, of which 57 have vested and have converted into ordinary shares. The remaining 114 Restricted Stock Units will vest in two annual installments, with 57 Restricted Stock Units vesting on June 10, 2023 and 57 Restricted Stock Units vesting on June 10, 2024.

(4) 58 options vested on June 10, 2022 and remain exercisable. The remaining 117 options will vest in two equal annual installments on June 10, 2023 and June 10, 2024.

**Remarks:**
Head of Finance & Group Controller, Principal Accounting Officer

**Signature:** /s/ Vittoria Bonasso  
**Date:** 2023-02-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**